1. Home
  2. APGE vs BMA Comparison

APGE vs BMA Comparison

Compare APGE & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.61

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Banco Macro S.A.  ADR (representing Ten Class B)

BMA

Banco Macro S.A. ADR (representing Ten Class B)

HOLD

Current Price

$98.61

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
BMA
Founded
2022
1966
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.4B
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
APGE
BMA
Price
$132.61
$98.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$109.67
$99.33
AVG Volume (30 Days)
1.2M
339.8K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
4.99%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.25
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$33.22
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$38.30
52 Week High
$95.32
$106.15

Technical Indicators

Market Signals
Indicator
APGE
BMA
Relative Strength Index (RSI) 81.67 64.96
Support Level $75.41 $84.83
Resistance Level N/A $106.15
Average True Range (ATR) 4.83 4.35
MACD 3.35 0.88
Stochastic Oscillator 99.30 76.61

Price Performance

Historical Comparison
APGE
BMA

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

Share on Social Networks: